SOBI Reports 3% Revenue Increase in Q1 2025, Driven by Haematology Growth Amid Immunology Challenges
Swedish Orphan Biovitrum AB (SOBI) reported a 3% increase in Q1 2025 revenue to SEK 6,465 million, driven by growth in its haematology segment.
2 minutes to read